These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7857035)

  • 1. [Vaccinal prospect in cancerology].
    Bellet D
    Ann Pharm Fr; 1994; 52(5):266-8. PubMed ID: 7857035
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulocyte-macrophage colony-stimulating factor gene-modified vaccines for immunotherapy of cancer.
    Bubeník J
    Folia Biol (Praha); 1999; 45(4):115-9. PubMed ID: 10732724
    [No Abstract]   [Full Text] [Related]  

  • 3. Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy.
    Schreurs MW; Eggert AA; Punt CJ; Figdor CG; Adema GJ
    Crit Rev Oncog; 2000; 11(1):1-17. PubMed ID: 10795625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy: the last 25 years.
    Plunkett TA; Miles DW
    Cancer Treat Rev; 1999 Dec; 25(6):355-63. PubMed ID: 10644501
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cancer immunotherapy].
    Vakkila J; Pihkala U
    Duodecim; 1999; 115(7):785-94. PubMed ID: 11859512
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular approaches to cancer immunotherapy.
    Forni G; Cavallo F; Consalvo M; Allione A; Dellabona P; Casorati G; Giovarelli M
    Cytokines Mol Ther; 1995 Dec; 1(4):225-48. PubMed ID: 9384678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell transfer and other immunotherapeutic strategies.
    Rosenberg SA
    Clin Adv Hematol Oncol; 2005 Jan; 3(1):28-9. PubMed ID: 16166964
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current and future aspects of human tumor immunotherapy].
    Sato N; Ikeda H; Tamura Y; Sahara H; Torigoe T
    Hokkaido Igaku Zasshi; 2003 Jan; 78(1):7-9. PubMed ID: 12613018
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer vaccines in gene therapy.
    Blankenstein T; Qin Z
    Gene Ther; 1996 Feb; 3(2):95-6. PubMed ID: 8867856
    [No Abstract]   [Full Text] [Related]  

  • 10. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
    Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoprevention of cancer: time to reconsider timing of vaccination against cancer.
    Spisek R
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1689-91. PubMed ID: 17181481
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of activated natural killer cells for tumor immunotherapy in mouse and human.
    Basse PH; Whiteside TL; Herberman RB
    Methods Mol Biol; 2000; 121():81-94. PubMed ID: 10818719
    [No Abstract]   [Full Text] [Related]  

  • 13. CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy.
    Jahrsdörfer B; Weiner GJ
    Curr Opin Investig Drugs; 2003 Jun; 4(6):686-90. PubMed ID: 12901226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current developments in cancer vaccines and cellular immunotherapy.
    Ribas A; Butterfield LH; Glaspy JA; Economou JS
    J Clin Oncol; 2003 Jun; 21(12):2415-32. PubMed ID: 12805342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer vaccines and immunotherapies: emerging perspectives.
    Henderson RA; Mossman S; Nairn N; Cheever MA
    Vaccine; 2005 Mar; 23(17-18):2359-62. PubMed ID: 15755628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the efficacy of cancer immunotherapy.
    Copier J; Dalgleish AG; Britten CM; Finke LH; Gaudernack G; Gnjatic S; Kallen K; Kiessling R; Schuessler-Lenz M; Singh H; Talmadge J; Zwierzina H; Håkansson L
    Eur J Cancer; 2009 May; 45(8):1424-31. PubMed ID: 19167214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to immunoprevention and immunotherapy of neoplasms.
    Glushkov AN
    Russ J Immunol; 2002 Oct; 7(3):219-28. PubMed ID: 12674931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunology: new approaches to immuno-modulation and immunotherapy].
    Kabelitz D
    Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1471-3. PubMed ID: 16794979
    [No Abstract]   [Full Text] [Related]  

  • 20. Toll-like receptor ligands energize peptide vaccines through multiple paths.
    Celis E
    Cancer Res; 2007 Sep; 67(17):7945-7. PubMed ID: 17804699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.